These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

158 related articles for article (PubMed ID: 24995121)

  • 41. Comparison of efficacy, safety, and cost-effectiveness of various statins in dyslipidemic diabetic patients.
    Bener A; Dogan M; Barakat L; Al-Hamaq AO
    Indian J Pharmacol; 2014; 46(1):88-93. PubMed ID: 24550591
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Effects of rosuvastatin versus atorvastatin, simvastatin, and pravastatin on non-high-density lipoprotein cholesterol, apolipoproteins, and lipid ratios in patients with hypercholesterolemia: additional results from the STELLAR trial.
    Jones PH; Hunninghake DB; Ferdinand KC; Stein EA; Gold A; Caplan RJ; Blasetto JW;
    Clin Ther; 2004 Sep; 26(9):1388-99. PubMed ID: 15531001
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Justification for the Use of Statins in Primary Prevention: an Intervention Trial Evaluating Rosuvastatin (JUPITER)--can C-reactive protein be used to target statin therapy in primary prevention?
    Mora S; Ridker PM
    Am J Cardiol; 2006 Jan; 97(2A):33A-41A. PubMed ID: 16442935
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Association of cholesteryl ester transfer protein mass with peripheral leukocyte count following statin therapy: a pilot study.
    Tani S; Nagao K; Hirayama A
    Am J Cardiovasc Drugs; 2012 Oct; 12(5):349-54. PubMed ID: 22900989
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Cholesterol level goal attainment with statins: clinical management guideline recommendations versus management in actual clinical practice.
    Heintjes EM; Penning-van Beest FJ; Plat AW; Meerding WJ; Webb K; Sturkenboom MC; Herings RM
    Pharmacotherapy; 2012 Jul; 32(7):631-41. PubMed ID: 22760692
    [TBL] [Abstract][Full Text] [Related]  

  • 46. CX3CL1-Fc treatment prevents atherosclerosis in Ldlr KO mice.
    Riopel M; Vassallo M; Ehinger E; Pattison J; Bowden K; Winkels H; Wilson M; de Jong R; Patel S; Balakrishna D; Bilakovics J; Fanjul A; Plonowski A; Larson CJ; Ley K; Cabrales P; Witztum JL; Olefsky JM; Lee YS
    Mol Metab; 2019 Feb; 20():89-101. PubMed ID: 30553772
    [TBL] [Abstract][Full Text] [Related]  

  • 47. [Effect of rosuvastatin therapy and myocardial revascularization on angiogenesis in coronary artery disease patients].
    Semenova AE; Sergienko IV; Masenko VP; Gabrusenko SA; Kukharchuk VV; Belenkov IuN
    Kardiologiia; 2007; 47(11):4-8. PubMed ID: 18260956
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Fractalkine/CX3CL1 production by human aortic smooth muscle cells impairs monocyte procoagulant and inflammatory responses.
    Ollivier V; Faure S; Tarantino N; Chollet-Martin S; Deterre P; Combadière C; de Prost D
    Cytokine; 2003 Mar; 21(6):303-11. PubMed ID: 12824004
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Twelve-week, multicenter, randomized, open-label comparison of the effects of rosuvastatin 10 mg/d and atorvastatin 10 mg/d in high-risk adults: a DISCOVERY study.
    Strandberg TE; Feely J; Sigurdsson EL;
    Clin Ther; 2004 Nov; 26(11):1821-33. PubMed ID: 15639694
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Fractalkine is a novel human adipochemokine associated with type 2 diabetes.
    Shah R; Hinkle CC; Ferguson JF; Mehta NN; Li M; Qu L; Lu Y; Putt ME; Ahima RS; Reilly MP
    Diabetes; 2011 May; 60(5):1512-8. PubMed ID: 21525510
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Relationship between circulating microRNA-30c with total- and LDL-cholesterol, their circulatory transportation and effect of statins.
    Sodi R; Eastwood J; Caslake M; Packard CJ; Denby L
    Clin Chim Acta; 2017 Mar; 466():13-19. PubMed ID: 28062296
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Switching to aggressive statin improves vascular endothelial function in patients with stable coronary artery disease.
    Hoshiga M; Arishiro K; Nakakoji T; Miyazaki N; Negoro N; Okabe T; Kohbayashi E; Ishihara T; Hanafusa T
    J Atheroscler Thromb; 2010 Jul; 17(7):705-11. PubMed ID: 20065610
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Tear cytokine and chemokine analysis and clinical correlations in evaporative-type dry eye disease.
    Enríquez-de-Salamanca A; Castellanos E; Stern ME; Fernández I; Carreño E; García-Vázquez C; Herreras JM; Calonge M
    Mol Vis; 2010 May; 16():862-73. PubMed ID: 20508732
    [TBL] [Abstract][Full Text] [Related]  

  • 54. 2013 Cholesterol Guidelines Revisited: Percent LDL Cholesterol Reduction or Attained LDL Cholesterol Level or Both for Prognosis?
    Bangalore S; Fayyad R; Kastelein JJ; Laskey R; Amarenco P; DeMicco DA; Waters DD
    Am J Med; 2016 Apr; 129(4):384-91. PubMed ID: 26551986
    [TBL] [Abstract][Full Text] [Related]  

  • 55. More Western hypercholesterolemic patients achieve Japan Atherosclerosis Society LDL-C goals with rosuvastatin therapy than with atorvastatin, pravastatin, or simvastatin therapy.
    Strutt K; Caplan R; Hutchison H; Dane A; Blasetto J
    Circ J; 2004 Feb; 68(2):107-13. PubMed ID: 14745143
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Shear Stress Counteracts Endothelial CX3CL1 Induction and Monocytic Cell Adhesion.
    Babendreyer A; Molls L; Dreymueller D; Uhlig S; Ludwig A
    Mediators Inflamm; 2017; 2017():1515389. PubMed ID: 28522896
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Rosuvastatin, pravastatin, and atorvastatin for the treatment of hypercholesterolaemia in HIV-infected patients receiving protease inhibitors.
    Calza L; Manfredi R; Colangeli V; Pocaterra D; Pavoni M; Chiodo F
    Curr HIV Res; 2008 Nov; 6(6):572-8. PubMed ID: 18991624
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Effectiveness of rosuvastatin in low-density lipoprotein cholesterol lowering and National Cholesterol Education Program Adult Treatment Panel guideline III LDL-C goal attainment compared to other statins among diabetes mellitus patients: a retrospective study using an electronic medical records dataset in the United States.
    Fox KM; Gandhi SK; Ohsfeldt RL; Blasetto JW; Bays HE
    Curr Med Res Opin; 2007 Sep; 23(9):2125-33. PubMed ID: 17655813
    [TBL] [Abstract][Full Text] [Related]  

  • 59. The influence of rosuvastatin therapy and percutaneous coronary intervention on angiogenic growth factors in coronary artery disease patients.
    Semenova AE; Sergienko IV; Masenko VP; Ezhov MV; Gabrusenko SA; Kuharchuk VV; Belenkov YN
    Acta Cardiol; 2009 Jun; 64(3):405-9. PubMed ID: 19593954
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Achievement of LDL-cholesterol goal with statins after an st segment elevation myocardial infarction.
    Tungsubutra W; Phongtuntakul B
    J Med Assoc Thai; 2015 Feb; 98(2):129-36. PubMed ID: 25842792
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.